346 research outputs found
sj-docx-1-tam-10.1177_17588359231220506 – Supplemental material for Nomogram to predict the presence of PSMA-negative but FDG-positive lesion in castration-resistant prostate cancer: a multicenter cohort study
Supplemental material, sj-docx-1-tam-10.1177_17588359231220506 for Nomogram to predict the presence of PSMA-negative but FDG-positive lesion in castration-resistant prostate cancer: a multicenter cohort study by Jian Pan, Tingwei Zhang, Shouzhen Chen, Ting Bu, Jinou Zhao, Xudong Ni, Benkang Shi, Hualei Gan, Yu Wei, Qifeng Wang, Beihe Wang, Junlong Wu, Shaoli Song, Feng Wang, Chang Liu, Dingwei Ye and Yao Zhu in Therapeutic Advances in Medical Oncology</p
Re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the Value of Number of Cycles of Docetaxel and Prednisone in Men with Metastatic Castration-Resistant Prostate Cancer. Eur Urol 2012;61:363–9
PD66-05 INTRAOPERATIVE FROZEN SECTION EVALUATION OF THE TUMOR AND ITS BASE IN PATIENTS WITH T1 UROTHELIAL BLADDER CANCER UNDERWENT TRANSURETHRAL RESECTION
Re: Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease
Re: Daher C. Chade, Shahrokh F. Shariat, Angel M. Cronin, et al. Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Multi-institutional Collaboration. Eur Urol 2011;60:205–10
Re: Beat Roth, Frédéric D. Birkhäuser, Pascal Zehnder, et al. Readaptation of the Peritoneum Following Extended Pelvic Lymphadenectomy and Cystectomy Has a Significant Beneficial Impact on Early Postoperative Recovery and Complications: Results of a Prospective Randomized Trial. Eur Urol 2011;59:204–10
Re: Hassan Abol-Enein, Derya Tilki, Ahmed Mosbah, et al. Does the Extent of Lymphadenectomy in Radical Cystectomy for Bladder Cancer Influence Disease-Free Survival? A Prospective Single-Center Study. Eur Urol 2011;60:572–7
Re: Jutta Engel, Patrick J. Bastian, Helmut Baur, et al. Survival Benefit of Radical Prostatectomy in Lymph Node–Positive Patients with Prostate Cancer. Eur Urol 2010;57:754–61
- …
